Article Sidebar

PDF (Tiếng Việt)
Published: 2023-08-22
Abstract Views: 188
Views PDF (Tiếng Việt): 166
DOI: https://doi.org/10.52852/tcncyh.v168i7.1738
Issue
Vol. 168 No. 7 (2023)
Section
Các bài báo
How to Cite
Minh, N. Q. ., Mai, L. T. ., Hiếu, D. P. ., Hà, V. T. ., & Doanh, L. H. . (2023). 7. Results of treatment of crow’s feet with Botulinum toxin type A injection at the National Hospital of Dermatology. Journal of Medical Research, 168(7), 57-66. https://doi.org/10.52852/tcncyh.v168i7.1738

7. Results of treatment of crow's feet with Botulinum toxin type A injection at the National Hospital of Dermatology

Nguyen Quang Minh, Le Thi Mai, Duong Phuc Hieu, Vu Thai Ha, Le Huu Doanh

Main Article Content

Abstract

Crow's feet are a sign of skin aging. Currently, Botulinum toxin injection is considered safe and highly effective treatment. We conducted a study on 60 patients diagnosed with crow's feet at the Department of Stem Cell Research and Application of the National Hospital of Dermatology, from July to December 2020 to evaluate the effectiveness and side effects of Botulinum toxin type A injection. The effectiveness is evaluated based on the reduction of Facial wrinkle scale. The results showed that after 1 month of treatment, all patients improved, of which 83.3% improved significantly. Side effects were low, 3 patients (5%) had post-injection bruising and 3 patients (5%) had a feeling of eyelid tightness during the first week which subsides after one month.

Article Details

Keywords

Botulinum toxin type A, crow’s feet, National Hospital of Dermatology

References

1. Carruthers A, Carruthers J, Hardas B, et al. A Validated Grading Scale for Crow’s Feet. Dermatol Surg. 2008;34:S173.
2. Ascher B, Rzany BJ, Grover R. Efficacy and safety of botulinum toxin type A in the treatment of lateral crow’s feet: Double-blind, placebo-controlled, dose-ranging study. Dermatol Surg Off Publ Am Soc Dermatol Surg Al. 2009;35(10):1478-1486. doi:10.1111/j.1524-4725.2009.01261.x
3. Carruthers A, Bruce S, de Coninck A, et al. Efficacy and safety of onabotulinumtoxinA for the treatment of crows feet lines: a multicenter, randomized, controlled trial. Dermatol Surg. 2014;40(11):1181-1190. doi:10.1097/dss.0000 000000000128
4. Harii K, Kawashima M, Furuyama N, et al. OnabotulinumtoxinA (Botox) in the Treatment of Crow’s Feet Lines in Japanese Subjects. Aesthetic Plast Surg. 2017;41(5):1186-1197. doi:10.1007/s00266-017-0844-9
5. Carruthers A, Bruce S, Cox SE, et al. OnabotulinumtoxinA for Treatment of Moderate to Severe Crow’s Feet Lines: A Review. Aesthet Surg J. 2016;36(5):591-597. doi:10.1093/asj/sjw025
6. Prager W, Wissmüller E, Kollhorst B, et al. Treatment of crow’s feet with two different botulinum toxin type A preparations in split-face technique. Hautarzt Z Dermatol Venerol Verwandte Geb. 2011;62(5):375-379. doi:10.1007/s00105-011-2148-3
7. Kane MAC, Cox SE, Jones D, et al. Heterogeneity of Crow’s Feet Line Patterns in Clinical Trial Subjects. Dermatol Surg. 2015;41(4):447. doi:10.1097/DSS.0000000000 000336
8. Cheng CM. Cosmetic use of botulinum toxin type A in the elderly. Clin Interv Aging. 2007;2(1):81-83. doi:10.2147/ciia.2007.2.1.81
9. Baumann L, Dayan S, Connolly S, et al. Duration of Clinical Efficacy of OnabotulinumtoxinA in Crow’s Feet Lines: Results from Two Multicenter, Randomized, Controlled Trials. Dermatol Surg. 2016;42(5):598-607. doi:10.1097/DSS.0000000000000757
10. Lowe NJ, Lask G, Yamauchi P, et al. Bilateral, double-blind, randomized comparison of 3 doses of botulinum toxin type A and placebo in patients with crow’s feet. J Am Acad Dermatol. 2002;47(6):834-840. doi:10.1067/mjd.2002.124070
11. Seo KK. Wrinkle Treatment with Botulinum Toxin. In: Seo KK, ed. Botulinum Toxin for Asians. Springer; 2017:29-105. doi:10.1007/978-981-10-0204-5_2